Letairis® (ambrisentan) logo
For HCPs

Letairis (ambrisentan) is a prescription medicine used to treat pulmonary arterial hypertension (PAH), which is high blood pressure in the arteries of the lungs.

Stay on track with supportSupport from LEAP is only available with
branded Letairis

The LEAP patient support program will continue to provide support for patients taking branded Letairis

LEAP is a support program for all patients who have been prescribed Letairis regardless of the type of insurance they have or if they do not have insurance.

You can rely on LEAP to provide:

  • Information to help you better understand your insurance benefits and out-of-pocket costs
  • Information about financial support resources to help you afford the out-of-pocket costs for Letairis
  • Guidance on how to work with your Certified Pharmacy to make sure you receive your Letairis shipment on time each month

Because of the risk of serious birth defects, females can only receive Letairis through a restricted program called the Letairis Risk Evaluation and Mitigation Strategy (REMS) Program. All females must enroll in the Letairis REMS Program to receive Letairis.

To learn more about how LEAP may help, call  

Just starting treatment? Read step-by-step instructions on how to get started on Letairis here.

Need help affording your medication? Learn about financial options.

TAP FOR IMPORTANT SAFETY INFORMATION INCLUDING AN IMPORTANT WARNING ON SERIOUS BIRTH DEFECTS IF TAKEN DURING PREGNANCY.
TAP FOR IMPORTANT SAFETY INFORMATION INCLUDING AN IMPORTANT WARNING ON SERIOUS BIRTH DEFECTS IF TAKEN DURING PREGNANCY.